| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/20/2023 |
SC 13G
| Roumell Asset Management, LLC reports a 7% stake in GSI Technology, Inc. |
| 02/11/2022 |
SC 13G/A
| Roumell Asset Management, LLC reports a 0.6% stake in TETRA Technologies Inc. |
| 02/11/2022 |
SC 13G
| Roumell Asset Management, LLC reports a 6.2% stake in Qumu Corporation |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2022 |
SC 13D/A
| Roumell Asset Management, LLC reports a 3.3% stake in BioCardia, Inc. |
| 01/20/2022 |
SC 13D/A
| Roumell Asset Management, LLC reports a 8.1% stake in GSI Technology, Inc. |
| 09/30/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 6% stake in Enzo Biochem, Inc. |
| 09/22/2021 |
SC 13D
| Roumell Asset Management, LLC reports a 5.6% stake in BioCardia, Inc. |
| 09/14/2021 |
SC 13D
| Roumell Asset Management, LLC reports a 8.1% stake in GSI Technology, Inc. |
| 05/05/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 6% stake in Enzo Biochem, Inc. |
| 02/12/2021 |
SC 13G
| Roumell Asset Management, LLC reports a 5.7% stake in GSI Technology Inc. |
| 02/12/2021 |
SC 13G
| Roumell Asset Management, LLC reports a 8.2% stake in TETRA Technologies Inc. |
| 02/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/15/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 01/05/2021 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/31/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/23/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/22/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/21/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/18/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/14/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/08/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/07/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 12/04/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 11/27/2020 |
SC 13D
| Roumell Asset Management, LLC reports a 5.8% stake in Enzo Biochem, Inc. |
| 07/01/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 1% stake in Liquidity Services, Inc. |
| 04/17/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 4% stake in ZAGG Inc. |
| 04/03/2020 |
SC 13D/A
| Roumell Asset Management, LLC reports a 4% stake in ZAGG Inc. |
| 03/11/2020 |
SC 13D
| Roumell Asset Management, LLC reports a 3.3% stake in Liquidity Services, Inc. |
| 07/25/2019 |
SC 13D/A
| Roumell Asset Management, LLC reports a 0% stake in Enzo Biochem Inc. |
| 03/26/2019 |
SC 13D
| Roumell Asset Management, LLC reports a 4.1% stake in Enzo Biochem Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|